Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid ...
CAGR is driven by advancements in epigenetics research, methylation analysis technologies, and the rising need for ...
TipRanks on MSN
Veritas in silico files patent for first-in-class mRNA-targeted drug for post-surgery kidney injury
Veritas In Silico Inc. ( ($JP:130A) ) has issued an update. Veritas In Silico has filed a substance patent application in Japan for a ...
As tough as medieval chainmail armor and as soft as a contact lens. This material is not taken from science fiction, it is a ...
CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...
The research team from the Diagnostic Sensor Research Lab at the Korea Institute of Machinery and Materials, which developed ...
JABSOM Cell and Molecular Biology researcher Dr. Jesse Owens has spent the better part of two decades chasing a vision that ...
TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight ...
AllAfrica on MSN
MRU member states adopt communiqué in Monrovia to strengthen transboundary water governance
Participants at a three-day Mano River Union (MRU) regional validation workshop adopted a landmark communiqué in Monrovia on December 18, 2025, calling for the establishment and operationalization of ...
But whilst undeniably (and impressively) old, living through such events as the Aztec Empire and the exploding whale incident ...
News-Medical.Net on MSN
SARS-CoV-2 manipulates host cell's RNA to weaken the immune response
Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes COVID-19, uses a sophisticated tactic to evade the human body's defense ...
Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results